BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14604530)

  • 1. Structure of the yeast Hst2 protein deacetylase in ternary complex with 2'-O-acetyl ADP ribose and histone peptide.
    Zhao K; Chai X; Marmorstein R
    Structure; 2003 Nov; 11(11):1403-11. PubMed ID: 14604530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and autoregulation of the yeast Hst2 homolog of Sir2.
    Zhao K; Chai X; Clements A; Marmorstein R
    Nat Struct Biol; 2003 Oct; 10(10):864-71. PubMed ID: 14502267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of substrate analogs and mutagenesis to study substrate binding and catalysis in the Sir2 family of NAD-dependent protein deacetylases.
    Khan AN; Lewis PN
    J Biol Chem; 2006 Apr; 281(17):11702-11. PubMed ID: 16520376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for nicotinamide cleavage and ADP-ribose transfer by NAD(+)-dependent Sir2 histone/protein deacetylases.
    Zhao K; Harshaw R; Chai X; Marmorstein R
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8563-8. PubMed ID: 15150415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases.
    Borra MT; Langer MR; Slama JT; Denu JM
    Biochemistry; 2004 Aug; 43(30):9877-87. PubMed ID: 15274642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and chemistry of the Sir2 family of NAD+-dependent histone/protein deactylases.
    Marmorstein R
    Biochem Soc Trans; 2004 Dec; 32(Pt 6):904-9. PubMed ID: 15506920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and substrate binding properties of cobB, a Sir2 homolog protein deacetylase from Escherichia coli.
    Zhao K; Chai X; Marmorstein R
    J Mol Biol; 2004 Mar; 337(3):731-41. PubMed ID: 15019790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assembly of the SIR complex and its regulation by O-acetyl-ADP-ribose, a product of NAD-dependent histone deacetylation.
    Liou GG; Tanny JC; Kruger RG; Walz T; Moazed D
    Cell; 2005 May; 121(4):515-527. PubMed ID: 15907466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetyl-lysine analog peptides as mechanistic probes of protein deacetylases.
    Smith BC; Denu JM
    J Biol Chem; 2007 Dec; 282(51):37256-65. PubMed ID: 17951578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unstructured conformations are a substrate requirement for the Sir2 family of NAD-dependent protein deacetylases.
    Khan AN; Lewis PN
    J Biol Chem; 2005 Oct; 280(43):36073-8. PubMed ID: 16131486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for the NAD-dependent deacetylase mechanism of Sir2.
    Chang JH; Kim HC; Hwang KY; Lee JW; Jackson SP; Bell SD; Cho Y
    J Biol Chem; 2002 Sep; 277(37):34489-98. PubMed ID: 12091395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of nicotinamide inhibition and transglycosidation by Sir2 histone/protein deacetylases.
    Jackson MD; Schmidt MT; Oppenheimer NJ; Denu JM
    J Biol Chem; 2003 Dec; 278(51):50985-98. PubMed ID: 14522996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based mechanism of ADP-ribosylation by sirtuins.
    Hawse WF; Wolberger C
    J Biol Chem; 2009 Nov; 284(48):33654-61. PubMed ID: 19801667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural identification of 2'- and 3'-O-acetyl-ADP-ribose as novel metabolites derived from the Sir2 family of beta -NAD+-dependent histone/protein deacetylases.
    Jackson MD; Denu JM
    J Biol Chem; 2002 May; 277(21):18535-44. PubMed ID: 11893743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of a Sir2 enzyme bound to an acetylated p53 peptide.
    Avalos JL; Celic I; Muhammad S; Cosgrove MS; Boeke JD; Wolberger C
    Mol Cell; 2002 Sep; 10(3):523-35. PubMed ID: 12408821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIR2: the biochemical mechanism of NAD(+)-dependent protein deacetylation and ADP-ribosyl enzyme intermediates.
    Sauve AA; Schramm VL
    Curr Med Chem; 2004 Apr; 11(7):807-26. PubMed ID: 15078167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the catalytic mechanism of Sir2 enzyme with QM/MM approach: SN1 vs SN2?
    Liang Z; Shi T; Ouyang S; Li H; Yu K; Zhu W; Luo C; Jiang H
    J Phys Chem B; 2010 Sep; 114(36):11927-33. PubMed ID: 20726530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coupling of histone deacetylation to NAD breakdown by the yeast silencing protein Sir2: Evidence for acetyl transfer from substrate to an NAD breakdown product.
    Tanny JC; Moazed D
    Proc Natl Acad Sci U S A; 2001 Jan; 98(2):415-20. PubMed ID: 11134535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for nicotinamide inhibition and base exchange in Sir2 enzymes.
    Sanders BD; Zhao K; Slama JT; Marmorstein R
    Mol Cell; 2007 Feb; 25(3):463-72. PubMed ID: 17289592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sir2 protein deacetylases: evidence for chemical intermediates and functions of a conserved histidine.
    Smith BC; Denu JM
    Biochemistry; 2006 Jan; 45(1):272-82. PubMed ID: 16388603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.